CLIENT FEATURE: CardioComm Solutions (EKG: TSX-V)

Has Finger On Pulse Of $149b mHealth Apps Market

 Why CardioComm?

1. CardioComm has 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
2. CardioComm Solutions has a unique position in the medical diagnostic industry as an FDA cleared, ISO certified and Health Canada/CE approved the company for the development, sale and marketing of medical software and devices.
3. CardioComm Solutions owns its own source code, unlike its competitors who typically acquired source code licenses.
4. CardioComm Solutions’ market advantage is that they are device agnostic allowing the CardioComm Solutions software to be plug and play with several different FDA-approved ECG recording devices. Any device that qualifies through their compliance program can be integrated into their system.
5. Class II medical device clearances and device-agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
6. ECG solutions for both consumer (OTC) and medical (Rx) markets
7. Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

What Does CardioComm Do?

1. CardioComm Solutions, Inc provides technically and clinically innovative software solutions for information management systems in cardiovascular medicine and telemedicine.
2. CardioComm's patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.
3. EKG produces ECG solutions for both consumer (OTC) and medical (Rx) markets. An electrocardiogram (ECG) records the electrical signal from your heart to check for different heart conditions.
4. The Company's software enables electrocardiography (ECG) data to be transmitted, received and managed anywhere in the world using standard computers, wireless devices, enterprise networks, telephones, or the Internet.
5. Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights:

February:

• CardioComm Solutions Expands ISO Clearance to Include Multiple Biosign Monitoring Device Integrations in Support of Remote Patient Monitoring Markets
  • to include pulse oximetry ("PO2"), blood pressure ("BP"), weight and temperature in addition to ECG monitoring hardware and software solutions.
  • As remote patient monitoring needs continue to grow so does the need for credible data to be collected from people outside of a hospital or medical office.
  • Many patients are using vital sign/bio sign devices at home for measurements of heart rate, temperature, blood pressure and oxygen saturation. Having easy to use accurate devices is a crucial part of safe virtual care.

January

• Appointment of a new Chief Financial Officer and completion of a debt to equity settlement.
• CardioComm Solutions, Inc. confirms the appointment of Ms. Josée Bertrand as the Company's Chief Financial Officer. Ms. Bertrand is an accomplished, results-driven senior accounting and financial management executive. She brings more than 30 years of progressive experience in finance and operations management in relevant industry sectors.

Market Analysis:

The global mHealth apps market size is expected to reach USD 149.3 billion by 2028 and is expected to register a CAGR of 17.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing promotion of mHealth applications due to their benefits in improving lifestyle and treatment outcomes is one of the key factors driving the growth of this market. In addition, the use of mobile health applications can facilitate better patient experience and engagement.

• The global market size is anticipated to be valued at USD 149.3 billion by 2028 owing to growing product adoption for better patient engagement and care
•  Based on type, the market is broadly classified into medical and fitness apps. The medical applications segment dominated the market in 2020
• This is owing to high awareness levels about such applications and preference for their use by healthcare professionals, patients, and other consumers
• Medical applications are further classified into applications, such as women's health, medication management, personal health record, diagnostic, remote monitoring, disease management, and others
• North America led the global market in 2020; however, Asia Pacific is projected to become the fastest-growing regional market over the forecast period.

Who Uses CardioComm?

Sold in >20 countries, with the largest customer base located in the US

Is CardioComm Approved?

CardioComm Solutions has approval and clearance from the following :

$EKG $EKG.ca

$ATE.ca $TLT.ca $ACST $IPA.ca $ARCH $NLH $WELL

CardioComm Solutions. is traded on the TSX.V as EKG.

For more information, visit: https://www.cardiocommsolutions.com/index.html

FULL DISCLOSURE: CardioComm Solutions is an advertising client of AGORA Internet Relations Corp.